Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Option exercise Director acquired 5,703 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Option exercise Director acquired 5,703 shares (option exercise)
  4. 4 Option exercise Director acquired 5,703 shares (option exercise)
  5. 4 Option exercise Director acquired 5,703 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 5,703 shares (option exercise)
  8. 4 Planned sale SVP, GLOBAL CONTROLLER sold 2,415 shares at $44.45 ($107,343)
  9. 4 Planned sale SVP, GLOBAL CONTROLLER sold 57,606 shares at an average $44.35 ($2,554,763)
  10. 4 Open-market sale PRESIDENT AND COO sold 7,879 shares at $44.21 ($348,364)
  11. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 27,279 shares at $44.21 ($1,206,122)
  12. 4 Open-market buy Director bought 549 shares at an average $44.11 ($24,214)
  13. 4 Open-market buy Director bought 2,298 shares at an average $43.31 ($99,518)
  14. 4 Open-market buy Director bought 1,915 shares at an average $43.69 ($83,661)
  15. 4 Open-market buy Director bought 1,602 shares at an average $45.40 ($72,724)
  16. 4 Open-market sale PRESIDENT AND COO sold 14,850 shares at an average $45.58 ($676,928)
  17. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 40,000 shares at an average $46.91 ($1,876,353)
  18. 4 Open-market sale PRESIDENT AND COO sold 2,627 shares at $48.22 ($126,681)
  19. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,102 shares at $48.22 ($438,921)
  20. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 1,064 shares at $48.22 ($51,309)

Page 5 of 18 · 355 filings